MODERN APPROACHES TO THE TREATMENT OF STABLE NON-SEGMENTAL VITILIGO: THE ROLE OF FLUOROURACIL IN COMBINATION THERAPY | Dermatovenereology and aesthetic medicine

MODERN APPROACHES TO THE TREATMENT OF STABLE NON-SEGMENTAL VITILIGO: THE ROLE OF FLUOROURACIL IN COMBINATION THERAPY

Digital Object Identifier (DOI) https://doi.org/10.67620/dermajournal.1730047
A.Sh. Inoyatov1 , J.Sh. Narziyev2
Received Sep 25, 2026
Revised Oct 10, 2026
Published Oct 15, 2026

Abstract

Vitiligo is a chronic skin disease characterized by depigmentation resulting from the destruction of melanocytes. One promising therapeutic approach is the use of fluorouracil, an antimetabolite with immunomodulatory and cytotoxic properties. The aim of this study is to evaluate the effectiveness of different fluorouracil treatment regimens in stable non-segmental vitiligo. Vitiligo affects approximately 1% of the population, and its etiology remains unclear, involving autoimmune, genetic, and external factors. Fluorouracil is traditionally used in oncology, but its ability to induce repigmentation makes it a potential candidate for the treatment of vitiligo. The aim of this study is to compare the effectiveness of different fluorouracil treatment regimens in patients with stable non-segmental vitiligo.

Keywords

—

How to Cite

APA style
A.Sh. Inoyatov (2026). MODERN APPROACHES TO THE TREATMENT OF STABLE NON-SEGMENTAL VITILIGO: THE ROLE OF FLUOROURACIL IN COMBINATION THERAPY. *Dermatovenereology and aesthetic medicine*, 17(3), 76. https://doi.org/10.67620/dermajournal.1730047